» Authors » M Deckert

M Deckert

Explore the profile of M Deckert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 106
Citations 2187
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Baudot A, Jeandel P, Mouska X, Maurer U, Tartare-Deckert S, Raynaud S, et al.
Oncogene . 2009 Jul; 28(37):3261-73. PMID: 19581935
B-cell chronic lymphocytic leukemia (B-CLL) is characterized by accumulation of mature monoclonal CD5+ B cells. The disease results mainly from a failure of cells to undergo apoptosis, a process largely...
12.
Pusch L, Romeike B, Deckert M, Mawrin C
Clin Neuropathol . 2009 Jun; 28(3):210-2. PMID: 19537140
We report on a 72-year-old patient in whom autopsy demonstrated incidentally intracerebral Toxoplasma gondii cysts, locally restricted in the occipital lobe, in association with only a few CD4+ and CD8+...
13.
Schwindt H, Vater I, Kreuz M, Montesinos-Rongen M, Brunn A, Richter J, et al.
Leukemia . 2009 Jun; 23(10):1875-84. PMID: 19494841
To determine the pattern of genetic alterations in primary central nervous system lymphomas (PCNSL), 19 PCNSL were studied by high-density single-nucleotide polymorphism arrays. Recurrent losses involved 6p21.32, 6q21, 8q12-12.2, 9p21.3,...
14.
Illerhaus G, Marks R, Muller F, Ihorst G, Feuerhake F, Deckert M, et al.
Ann Oncol . 2008 Oct; 20(2):319-25. PMID: 18953065
Background: To improve survival of elderly patients with primary central nervous system lymphoma (PCNSL), we conducted a phase II study with high-dose methotrexate (MTX) combined with procarbazine and CCNU. To...
15.
Turchi L, Aberdam E, Mazure N, Pouyssegur J, Deckert M, Kitajima S, et al.
Cell Death Differ . 2008 May; 15(9):1472-80. PMID: 18511933
In this study, we describe a novel activating transcription factor 3 (ATF3)-dependent death pathway triggered by ultraviolet (UV) irradiation. We demonstrate that ATF3 contributes to UV-induced apoptosis through the regulation...
16.
Hilmi C, Larribere L, Deckert M, Rocchi S, Giuliano S, Bille K, et al.
Pigment Cell Melanoma Res . 2008 Apr; 21(2):139-46. PMID: 18426407
Melanoma is a highly aggressive tumour characterized by a strong resistance to apoptotic stimuli that give rise to a selective advantage for tumour progression and metastasis formation. Therefore, it is...
17.
Montesinos-Rongen M, Brunn A, Bentink S, Basso K, Lim W, Klapper W, et al.
Leukemia . 2007 Nov; 22(2):400-5. PMID: 17989719
To characterize the molecular origin of primary lymphomas of the central nervous system (PCNSL), 21 PCNSLs of immunocompetent patients were investigated by microarray-based gene expression profiling. Comparison of the transcriptional...
18.
Ticchioni M, Essafi M, Jeandel P, Davi F, Cassuto J, Deckert M, et al.
Oncogene . 2007 May; 26(50):7081-91. PMID: 17496928
B-chronic lymphocytic leukemia (B-CLL) cell is characterized by the accumulation of long-lived CD5+ B lymphocytes, whose survival in vivo is in part dependent on exogenous factors such as cytokines and/or...
19.
Chassot A, Turchi L, Virolle T, Fitsialos G, Batoz M, Deckert M, et al.
Oncogene . 2007 Apr; 26(39):5772-83. PMID: 17404577
P27kip is a key inhibitory protein of the cell-cycle progression, which is rapidly downregulated in early G1 phase by a post-translational mechanism involving the proteosomal degradation. In this study, using...
20.
Kastner F, Paulus W, Deckert M, Schlegel P, Evers S, Husstedt I
Nervenarzt . 2007 Mar; 78(4):451-6. PMID: 17375274
We present a 31-year-old female patient with primary non-Hodgkin's lymphoma of the CNS after immunosuppressive therapy. Colitis ulcerosa had been diagnosed 2 years previously. Prophylactic therapy with azathioprine over 9...